Home / Companies / Novo Nordisk A/S / 27 Mar 2025
Novo Nordisk A/S: meeting of 27 Mar 2025
Votes reported on Form N-PX, item by item
357 Form N-PX filers reported votes at the Novo Nordisk A/S meeting of 27 Mar 2025. Their records fall into 10 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
8 nominees; 86.7% of reported votes for; 162 filers withheld from or voted against at least one nominee.
5,336 vote records from 296 filers. 7 of the 291 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
262 vote records from 114 filers. 2 of the 109 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
669 vote records from 295 filers. 12 of the 290 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
1,937 vote records from 295 filers. 0 of the 290 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
1,902 vote records from 298 filers. 3 of the 294 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
1,180 vote records from 265 filers. 0 of the 260 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
592 vote records from 41 filers. 0 of the 37 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.
HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESecurity holder
Approve Proposal Regarding Regulated Working Conditions at Construction Sites
456 vote records from 208 filers. 9 of the 204 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.
HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESecurity holder
Shareholder proposal: HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE
109 vote records from 58 filers. 2 of the 57 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
74 vote records from 38 filers. 3 of the 38 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor | 8. Proposal | 9. Proposal |
|---|---|---|---|---|---|
| Vanguard | For | For | For | Against | Against |
| BlackRock and iShares | For | For | For | No report | Against |
| Fidelity | For | No report | For | Against | No report |
| Dimensional | For | No report | For | Against | No report |
| State Street and SPDR | For | No report | For | Against | No report |
| American Century | For | No report | For | Against | No report |
| Franklin Templeton | For | No report | For | Against | No report |
| Invesco | For | No report | For | Against | No report |
| Equitable | For | No report | For | Against | No report |
| Charles Schwab | For | No report | For | No report | No report |
| Nuveen and TIAA | For | No report | For | Against | No report |
| ProShares and ProFunds | For | No report | For | Against | No report |
| John Hancock and Manulife | For | For | For | No report | Against |
| Morgan Stanley, Eaton Vance and Calvert | For | No report | For | Against | No report |
| J.P. Morgan | For | For | For | No report | Against |
| Goldman Sachs | For | No report | For | Against | No report |
| WisdomTree | For | No report | For | Against | No report |
| PGIM and Prudential | For | Split or no vote | For | Against | No report |
| Jackson National funds | For | For | For | No report | Against |
| Northern Trust and FlexShares | For | For | For | Against | No report |
| SEI | For | No report | For | No report | No report |
| T. Rowe Price | For | No report | For | Against | No report |
| Thrivent | For | No report | For | Against | No report |
| Lincoln Financial | For | For | For | Against * | Against |
| Voya | For | No report | For | Against | No report |
| First Trust | For | For | For | Against | Against |
| Russell Investments | For | No report | For | No report | No report |
| Nationwide | For | No report | For | Against | No report |
| Victory Capital | For | No report | For | Against | No report |
| Brighthouse Funds | For | For | For | Against * | Against * |
| Columbia Threadneedle | For | No report | For | Against | No report |
| BNY Mellon | For | No report | For | Against | No report |
| Principal | For | No report | For | Against | No report |
| Capital Group and American Funds | For | No report | For | Against | No report |
| Pacific Life funds | For | No report | For | Against | No report |
| Global X | For | No report | For | No report | No report |
| MFS | For | No report | For | Against | No report |
| Transamerica | For | No report | For | Against | No report |
| Federated Hermes | For | No report | For | No report | No report |
| AllianceBernstein | For | No report | For | Against | No report |
| Hartford Funds | For | No report | For | No report | No report |
| DWS | For | No report | For | Against | No report |
| PIMCO | For | No report | For | Against | No report |
| Allspring | For | No report | For | Against | No report |
| MassMutual | For | For | For | Against | No report |
| Harbor Funds | For | For | For | No report | Against |
| Virtus | For | No report | For | Against | No report |
| Macquarie and Delaware Funds | For | No report | For | Against | No report |
| Janus Henderson | For | No report | For | Against | No report |
| Neuberger Berman | For | No report | For | No report | No report |
| American Beacon | For | For | For | Against | Against |
| Natixis and Loomis Sayles | Abstain or withhold * | No report | Abstain or withhold * | No report | Against |
| Lord Abbett | For | No report | For | Against | No report |
| Artisan Partners | For | No report | For | No report | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Novo Nordisk A/S meeting?
357 Form N-PX filers reported votes at the meeting of 27 Mar 2025. On say-on-pay, 2 of 109 voted against management (1.8%). 2 proposals from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Novo Nordisk A/S on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Novo Nordisk A/S
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Novo Nordisk A/S with a meeting date within three days of 27 Mar 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.